Reply to: Nebulised liposomal amphotericin-B: a promising strategy for preventing ABPA relapse.

Godet, Cendrine; Cadranel, Jacques; Frat, Jean-Pierre; Ragot, Stéphanie; Couturaud, Francis

Godet, Cendrine; Cadranel, Jacques; Frat, Jean-Pierre; Ragot, Stéphanie; Couturaud, Francis.

Affiliation

Godet C; Assistance Publique - Hôpitaux de Paris, Hôpital Bichat, Service de Pneumologie, Paris, France cendrine.godet@aphp.fr.
Cadranel J; Assistance Publique - Hôpitaux de Paris, Hôpital Tenon, Service de Pneumologie et Oncologie thoracique, Centre constitutif Maladies pulmonaires rares and Sorbonne Université, Paris, France.
Frat JP; CHU Poitiers, Médecine Intensive Réanimation, Poitiers, France.
Ragot S; INSERM, CIC-1402, IS-ALIVE, Université de Poitiers, Poitiers, France.
Couturaud F; INSERM, CIC-1402, Biostatistics, Poitiers, France.

Eur Respir J ; 60(5)2022 11.

Article in En | MEDLINE | ID: mdl-36137593

Subject(s)

Amphotericin B; Aspergillosis, Allergic Bronchopulmonary; Humans; Aspergillosis, Allergic Bronchopulmonary/drug therapy; Antifungal Agents/therapeutic use; Recurrence

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aspergillosis, Allergic Bronchopulmonary / Amphotericin B Limits: Humans Language: En Journal: Eur Respir J Year: 2022 Document type: Article Affiliation country: France Publication country: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google